GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway
Immune cells and other cells respond to nutrient deprivation by the classic catabolic pathway of AMPK (Adenosine monophosphate kinase). This kinase is a pivotal regulator of glucose and fatty acids metabolism, although current evidence highlights its role in immune regulation. Indeed AMPK, through a...
Main Authors: | Alessio Mazzieri, Giuseppe Basta, Riccardo Calafiore, Giovanni Luca |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1163288/full |
Similar Items
-
SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality
by: Mei Qiu, et al.
Published: (2021-12-01) -
Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality
by: Lixin Du, et al.
Published: (2022-08-01) -
Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status
by: Lixin Du, et al.
Published: (2022-09-01) -
GLP-1 RAs and SGLT-2 Inhibitors for Insulin Resistance in Nonalcoholic Fatty Liver Disease: Systematic Review and Network Meta-Analysis
by: Hongle Yan, et al.
Published: (2022-07-01) -
The role behind the scenes of Tregs and Th17s in Hashimoto’s thyroiditis: Toward a pivotal role of FOXP3 and BACH2
by: Alessio Mazzieri, et al.
Published: (2022-12-01)